Right parietal cryptococcoma in a young immunocompetent patient: illustrative case Authors: Fernando A. Vasconcelos, Vinicius M. Henriques, Thamyres Figueredo Silva, Gabrielly da Silva Costa, Gabriela M. Macedo, Daniella S. Souza, Mariangela B. Gonçalves, Ruy Castro Monteiro da Silva Filho, Fernando Guedes Published: 2026 ABSTRACT BACKGROUNDCryptococcoma is a rare form of CNS cryptococcosis, typically associated with immunocompromised patients. However, cases reported in immunocompetent individuals have been increasing in recent years and are often initially misdiagnosed.OBSERVATIONSA 39-year-old previously healthy male patient presented with progressive headache, left-sided hemiparesis, and tonic-clonic seizures. Imaging studies revealed a right parietal expansive lesion with perilesional edema, initially suggestive of a neoplasm. Because of the diagnostic uncertainty, resection of the lesion was performed, and histopathological analysis confirmed the diagnosis of cryptococcoma. The patient received antifungal therapy with amphotericin B and fluconazole and showed improvement in symptoms postoperatively.LESSONSCNS cryptococcosis presents with variable clinical manifestations depending on the patient’s immune status. In immunocompetent individuals, cryptococcomas are primarily characterized by granulomatous reactions. The mean age of incidence is 56 years, and the clinical course tends to be insidious. Etiological diagnosis can be challenging as imaging findings may mimic brain neoplasms, and laboratory tests often have low sensitivity in cases of parenchymal involvement. Thus, resection may be crucial for both diagnosis and treatment. Cryptococcoma should be included in the differential diagnosis of expansive brain lesions, even in immunocompetent patients. Early recognition and appropriate management are essential to prevent complications and improve prognosis. https://thejns.org/doi/10.3171/CASE25713 Cryptococcus neoformans was first described in 1894 by Sanfelice, and cryptococcosis was described for the first time in the same year by Busse.1 The involvement of the CNS by the fungus C. neoformans was first described in 1914 by Verse,1 and the first description in Brazil was by Almeida et al. in 1942.2 It is mainly associated with immunocompromised patients, such as those with AIDS, prolonged use of immunosuppressants or corticosteroids, or conditions such as tuberculosis and sarcoidosis.2–5 The transmission of the fungus occurs mainly through inhalation, which happens on contact with soil contaminated by bird droppings, followed by hematogenous dissemination.6,7 There are more than 30 species of Cryptococcus; however, only two subcomplexes are pathogenic to humans:8 C. neoformans, which is the most frequent infectious agent (99% of cases) and has 2 pathogenic species,9 and Cryptococcus gattii, which has 5 pathogenic species.10 In some cases, the C. gattii variant is responsible for the infection, being mainly associated with intraparenchymal granulomas and affecting immunocompetent patients.3,6 The C. gattii variant is generally observed in India, Northern Australia, Papua New Guinea, Brazil, China, the United States, Thailand, New Zealand, Southeast Asia, France, the Netherlands, Senegal, and South Africa.6,11,12 In the United States, this variant is found in Southern California and, more recently, North Carolina and southwestern Georgia.11,13 The epidemiological distribution of C. gattii also varies according to the genotype of the fungus species analyzed.11 Although it is uncommon, this condition has shown an increase in the last 10 years,14,15 highlighting the importance of reporting new cases, especially those in immunocompetent patients, which is rare. According to Pappas, only 20% of cases occur in immunocompetent individuals, representing a portion of the population that is frequently subject to misdiagnoses,16 as pointed out by Li et al., who reported a diagnostic error rate of 52%.3 The current report discusses a rare case of cryptococcosis in a young immunocompetent man. Illustrative Case A 39-year-old male patient, with no other previous comorbidities, was admitted to Miguel Couto Municipal Hospital with a complaint of holocranial headache for 4 months, associated with progressively worsening hemiparesis on the left side for 3 months. About 1 month before hospitalization, he began experiencing episodes of focal tonic-clonic seizures on the left side. On physical examination, he presented with left-sided hemiparesis with muscle strength grade 2 according to the Medical Research Council scale17 and no cognitive disturbances, sensibility deficits, or cranial nerve disfunction. A contrast-enhanced cranial CT study (Fig. 1) revealed a right parietal expansive lesion with heterogeneous contrast enhancement associated with perilesional edema. FIG. 1.A–C:Contrast-enhanced axial cranial CT scans showing a right parietal expansive lesion (star) with contrast enhancement and areas of hypodensity, associated with perilesional edema. The axial sections were obtained at different craniocaudal levels, with panel A representing the most cranial section and panel C the most caudal section. A–C:Contrast-enhanced axial cranial CT scans showing a right parietal expansive lesion (star) with contrast enhancement and areas of hypodensity, associated with perilesional edema. The axial sections were obtained at different craniocaudal levels, with panel A representing the most cranial section and panel C the most caudal section. The patient was treated with analgesic, anticonvulsant, and corticosteroid therapy. He showed improvement in the hemiparesis, from grade 2 to grade 3, and the seizures ceased. Radiographic imaging of the chest showed no abnormalities, nor did the hematological and biochemical parameters. HIV infection was ruled out through serological testing to aid in the differential diagnosis of infectious diseases of the CNS. Also, this patient had no underlying immunosuppressive condition: he was not a transplant patient, was not using corticosteroids, and had no autoimmune disease. Given the diagnostic uncertainty regarding the lesion’s etiology, a brain MRI study was requested (Fig. 2). FIG. 2.A–D:Gadolinium-enhanced axial brain MR images showing a right parietal expansive lesion (star) with contrast enhancement and areas of hyposignal, associated with perilesional edema and ventricular effacement. The axial sections were obtained at different craniocaudal levels, with panel A representing the most cranial section and panel D the most caudal section. A–D:Gadolinium-enhanced axial brain MR images showing a right parietal expansive lesion (star) with contrast enhancement and areas of hyposignal, associated with perilesional edema and ventricular effacement. The axial sections were obtained at different craniocaudal levels, with panel A representing the most cranial section and panel D the most caudal section. The MRI examination raised the possibility of a neoplastic lesion. This, combined with the patient’s clinical evolution (persistence of hemiparesis), led the team to opt for resection of the mass, for both diagnostic and therapeutic purposes. The lesion was completely removed and had a granulomatous appearance macroscopically. In the postoperative period, the patient’s paresis improved from grade 3 to grade 5, and he did not develop any new neurological symptoms. Histopathological analysis (Figs. 3 and 4) identified that the fungus specimen was consistent with cryptococcosis. FIG. 3.Histological section stained with periodic acid-Schiff (×100 magnification), showing numerous spherical structures with a gelatinous capsule amid necrotic and leukocytic material, compatible with the presence of cryptococci. FIG. 4.Histological section stained with periodic acid-Schiff (×400 magnification), showing numerous spherical structures with a gelatinous capsule amid necrotic and leukocytic material, compatible with the presence of cryptococci. Histological section stained with periodic acid-Schiff (×100 magnification), showing numerous spherical structures with a gelatinous capsule amid necrotic and leukocytic material, compatible with the presence of cryptococci. Histological section stained with periodic acid-Schiff (×400 magnification), showing numerous spherical structures with a gelatinous capsule amid necrotic and leukocytic material, compatible with the presence of cryptococci. Once the diagnosis of cryptococcoma was confirmed, intravenous antifungal therapy with amphotericin B for 2 weeks and oral fluconazole for 6 weeks was initiated, following a discussion with the hospital’s infection control committee. The patient showed good clinical progress and was discharged from the hospital 2 weeks after surgery, being referred for outpatient follow-up and functional rehabilitation. The patient underwent two postoperative CT studies, one the day after surgery and the other 1 day before hospital discharge; both showed the absence of complications and important radiological improvement. The images could not be recovered and therefore are not be included in this paper. Although the patient was clinically stable at follow-up with no more seizures or weakness, 6 months after hospital discharge he experienced a fulminant acute myocardial infarction that resulted in death. Informed Consent The necessary informed consent was obtained in this study. Discussion Observations Cryptococcosis can be understood as a clinical manifestation of infection by the fungus Cryptococcus.18 In the specialized literature, there are reports of involvement of almost all organs and tissues of the human body; however, the fungus exhibits high neurotropism,19 being the most common opportunistic fungal infection of the CNS in immunodeficient patients.20 There are an estimated 152,000 cases of infection per year globally, with 112,000 resulting in death.21 It also affects the lungs and can present as a disseminated disease.22 In immunocompromised individuals, cryptococcosis involving the CNS can manifest as meningitis, encephalitis, meningoencephalitis, or ventriculitis. In immunocompetent individuals, it may present as cryptococcoma, characterized by single or multifocal granulomatous reactions in the brain parenchyma due to the host’s local immune response.16,20,22 It is important to note that some authors, such as Pappas,16 believe that most of the nontransplant immunocompetent patients present some unknown immunosuppression, although this fact has not been proven. The most common age range of immunocompetent and nontransplanted patients with cryptococcoma is 50–59 years.16 The present case diverges from the standard age range presented in the literature, as the patient was 39. Some of the most common symptoms include fever, nausea, vomiting, headache, and altered consciousness. As the disease progresses, the patient may experience seizures, a reduced level of consciousness, and eventually coma.6,19 Generally, HIV-negative patients have a chronic disease course, complicating the diagnosis, with a mean symptom duration of 6–12 weeks.19 The clinical presentation of the patient in our case was also chronic and consistent with the symptoms reported in the literature. The diagnosis of cryptococcosis can be based on clinical, epidemiological, and/or laboratory parameters. In this case, histopathological analysis was among the tools used to reach the diagnosis because it allowed for the detection of Cryptococcus in the sample of the resected mass. Although it allowed identification of the genus of the agent, it did not enable determination of the species.23 In CSF analysis, there is usually lymphomonocytic pleocytosis (> 10 cells/mm3), hyperproteinorrachia, and hypoglycorrhachia.24 A predominance of polymorphonuclear cells may occur in immunocompetent individuals. The use of immunological tests, in which a diagnosis is made by detecting the capsular antigen of Cryptococcus spp. in plasma or CSF, is more difficult in cases of cryptococcoma, as false-negative results may occur.7,23 Immunological testing has the advantage of being a rapid test.23 In our patient, it was not performed because the lesion was thought to be a neoplasm. Among laboratory tests, culture is the gold standard for diagnosis and species determination, and is based on identification of the agent in body fluids (nasal exudate and CSF), as well as tissues, skin, nails, and lymph nodes.24 Other laboratory tests include mycological examination, direct examination (India ink), and semiquantitative CSF analysis.24 In the present case, the culture test was not performed since diagnosis was made based only on histopathological results. CT and MRI studies should be performed in cryptococcosis as a complementary tool to laboratory and clinical-epidemiological findings. In immunocompetent individuals, hydrocephalus and cryptococcomas can be observed.23 More specifically, on MRI examination the most common findings in immunocompetent individuals are leptomeningeal enhancement (55.5%), involvement of the perivascular space (33.3%), and cryptococcal granulomas (33.3%).25 In Fig. 2, it is possible to observe involvement of the perivascular space and a cryptococcoma, with parenchymal involvement by a granuloma, which is present in only 11.1% of cases. Cryptococcal lesions may have a tumor-like appearance on MRI.25 In the case presented by Osaigbovo et al.,26 cryptococcal infection was not initially considered, which may have contributed to the patient’s death due to late diagnosis. This illustrates the importance of considering cryptococcoma as an underlying cause of the symptoms. The differential diagnosis of cryptococcosis depends on the affected site, with the main ones being meningitis, tuberculous meningoencephalitis, and brain neoplasms.23 Prior to resection, the primary diagnostic suspicion was a neoplasm, given the clinical presentation and radiological characteristics observed; therefore, surgical intervention was chosen. Needle biopsy can be used in cases in which the probability of an infection is uncertain, or when the patient has a high intraoperative cardiovascular risk.27 In the presence of growing lesions, hemorrhage, significant perilesional edema, or neurological symptoms of structural compression, aspiration or excision of the abscess is preferred.23,27,28 In the review conducted by Li et al.,3 of 17 cases, 8 underwent open surgery along with antifungal treatment, and in 6 patients, biopsy was performed by needle or stereotactic methods. Although limited, many authors suggest that excision is superior to aspiration or biopsy of the brain abscess in any case, promoting early clinical improvement and antibiotic response, reducing the risk of re-collection.29–32 Intraoperatively, cryptococcoma is described as a shiny, pale and gelatinous nodule,33,34 often encapsulated.35 This pattern is consistent with the lesion resected from our patient. After lesion resection, drug therapy with amphotericin B and oral fluconazole was immediately initiated. Therapy can also be administered intrathecally, primarily used as salvage therapy due to failure of previous modalities.24 Frequently, cryptococcosis in immunocompetent patients presents with antifungal resistance,36 which was not the case for the individual in our report. Successful treatment may be indicated by negative yeast cultures in the CSF 2 weeks after the initiation of treatment, in association with clinical improvement of the patient.37 We searched the literature to see if any patient with cryptococcoma had a similar outcome to our case, but no significant correlation was found between Cryptococcus infection and the cause of death. Lessons Cryptococcoma is a manifestation of CNS involvement by Cryptococcus sp., and, although uncommon, it can affect patients with an intact immune system. This highlights the need to include it in the differential diagnosis of expansive brain lesions. Furthermore, the incidence of cryptococcoma in young and healthy individuals may be higher than previously thought, although it often goes unrecognized. Restricting the consideration of this disease to its typical presentations in patients with advanced HIV/AIDS or other forms of immunosuppression may lead to an overlooked diagnosis in individuals who do not present these conditions, which can increase the risk of complications due to late treatment. Acknowledgments We used ChatGPT (GPT-5.2, OpenAI) exclusively for translation of portions of the text into English. We subsequently reviewed, revised, and finalized all translated content manually. Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. Author Contributions Conception and design: Vasconcelos, Figueredo Silva. Acquisition of data: Vasconcelos, Figueredo Silva, Monteiro da Silva Filho. Analysis and interpretation of data: Souza, Vasconcelos, Henriques, Figueredo Silva, Gonçalves. Drafting the article: Souza, Vasconcelos, Henriques, Figueredo Silva, Macedo. Critically revising the article: Souza, Vasconcelos, Henriques, Figueredo Silva, Macedo, Gonçalves, Guedes. Reviewed submitted version of manuscript: Souza, Vasconcelos, Figueredo Silva, Costa, Macedo. Approved the final version of the manuscript on behalf of all authors: Souza. Statistical analysis: Vasconcelos, Figueredo Silva. Administrative/technical/material support: Vasconcelos, Figueredo Silva, Costa, Gonçalves, Monteiro da Silva Filho. Study supervision: Vasconcelos, Henriques, Figueredo Silva, Gonçalves, Monteiro da Silva Filho, Guedes. Correspondence Daniella S. Souza: Gaffrée and Guinle University Hospital (HUGG-Unirio/Ebserh), Rio de Janeiro, Brazil. daniella.souza@edu.unirio.br.